Biotech

Epstein Fallout: Joi Ito Resigns From MIT Media Lab, Multiple Boards

4 monthes ago   |   By Xconomy

The ripple effects from a report Friday in The New Yorker about ties between the MIT Media Lab and disgraced financier and convicted sex offender Jeffrey Epstein continue to spread. After Joi Ito resigned as the Media Lab's director on Saturday, he also relinquished high-profile board seats with The New York Times Company , the Knight Foundation , the MacArthur Foundation , and PureTech Health , a Boston-based biotech company. Ito also resigned a visiting professorship at Harvard Law School, according to a spokeswoman. These are nowhere near all the boards that Ito is listed as sitting on...
Read more ...

 

Ito out at PureTech, MIT after Epstein funding scandal exposed

Ito out at PureTech, MIT after Epstein funding scandal exposed

4 monthes ago   |   By Fierce Biotech

Joichi Ito has been forced out as head of the Media Lab at MIT as well as from biotech builder PureTech's board after financial ties to the deceased sex offender Jeffrey Epstein were uncovered.
Read more ...

 


Search by Tags

   Biotech      BioTech      Health      Boston      Boston blog main      Boston top stories      National blog main      National top stories      New York blog main      Bill gates      Connected camps      Digital Garage      Fundraising      Harvard law school      Japan society      Jeffrey Epstein      Joi Ito      Knight Foundation      Lawrence Lessig      Leon Black      Macarthur foundation      Media Lab      MIT      New York Times Company      New Yorker      Pure health      Resignations      Ronan farrow      Seth lloyd      The Engine      Xperience  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Eric Seaborg Eric Seaborg, a writer and author, outdoorsman and environmentalist, has a love for hiking that he shared with his father, the late chemist and Nobel laureate... Read more ...

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Matt Hufford, associate professor at Iowa State University, helped produce a 26-line maize pangenome assembly collection Maize researchers have been rejoicing over a New Year's... Read more ...

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme won accelerated FDA approval Thursday for a drug developed to treat the rare cancer epithelioid sarcoma. The regulatory decision for the Epizyme drug, tazemetostat... Read more ...

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

I'm astonished at the speed with which geneticists and epidemiologists are zeroing in on the Wuhan coronavirus. Nomenclature is still up in the air. The first name, “2019-nCoV”... Read more ...

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

MedImmune, AstraZeneca's biologics division, is no more. The pharmaceutical giant announced last year that the name would be retired as part of a research and development... Read more ...

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

Safety concerns stymied Sarepta Therapeutics' attempt to win FDA approval last August for golodirsen , its second Duchenne muscular dystrophy drug. But an appeal of the... Read more ...

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

The first treatment for a rare disease that causes eye bulging and double vision received an FDA nod on Tuesday, weeks ahead of the agency's March 8 deadline to review the... Read more ...

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

CRISPR gene editing offers the potential to selectively edit the genetic mutations causing inherited diseases, but Emendo Biotherapeutics CEO David Baram contends it's not... Read more ...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a... Read more ...

Bachem: EHS Coordinator

Bachem: Your Responsibilities The Environmental, Health and Safety Coordinator will be responsible for providing full time environmental health and sa Vista, CA, US ... Read more ...